U.S. market Closed. Opens in 5 hours 40 minutes

SQZ | SQZ Biotechnologies Company Stock Financials Income Statements Annual

(Stock Exchange: NYSE)
*Sign In to persist settings
Financial Year End2022-12-312021-12-312020-12-312019-12-312018-12-31
Revenue21.03M27.10M21.00M19.32M12.67M
Cost of RevenueN/AN/AN/AN/AN/A
Gross Profit21.03M27.10M21.00M19.32M12.67M
Operating Expenses96.85M95.87M72.06M53.58M31.94M
Selling, General & Admin26.32M25.72M20.51M18.27M8.69M
Research & Development70.98M70.15M51.55M36.10M24.38M
Other Operating Expenses-449.00K-8.00K-13.00K-791.00K-1.13M
Operating Income-80.68M-68.77M-51.06M-34.27M-20.40M
Other Expenses / Income1.22M28.00K537.00K2.06M1.15M
Before Tax Income-79.46M-68.74M-50.52M-32.20M-19.25M
Income Tax Expenses-1.22M-36.00K-550.00K-7.00K1.21M
Net Income-78.24M-68.70M-49.97M-32.20M-19.25M
Interest Expenses9.72MN/AN/AN/A59.00K
Basic Shares Outstanding28.81M27.58M5.40M17.92M14.41M
Diluted Shares Outstanding28.81M27.58M5.40M17.92M14.41M
EBITDA-59.28M-57.74M-40.12M-27.85M-18.12M
EBITDA Margin-281.91%-213.07%-191.04%-144.15%-143.06%
EBIT-69.75M-68.74M-50.52M-32.20M-17.98M
EBIT Margin-331.67%-253.68%-240.60%-166.69%-141.91%
Financial Year End2022-12-312021-12-312020-12-312019-12-312018-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙